Market closedNon-fractional

Inari Medical/NARI

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Inari Medical

Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.

Ticker

NARI

Sector

Healthcare

Trading on

NASDAQ

Industry

Health Care Equipment and Supplies

Headquarters

Irvine, United States

Employees

1,300

Inari Medical Metrics

BasicAdvanced
$2.9B
Market cap
-
P/E ratio
-$0.41
EPS
0.85
Beta
-
Dividend rate
$2.9B
0.85
2.712
2.091
6.657
7.042
-27.30%
-0.68%
-5.41%
5.53
6.5
31.67
155.57
26.10%
-21.42%
45.19%
9.50%

What the Analysts think about Inari Medical

Analyst Ratings

Majority rating from 11 analysts.
Buy

Inari Medical Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-16.91% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$143M
8.41%
Net income
-$24M
426.09%
Profit margin
-16.91%
385.92%

Inari Medical Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 9.93%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.05
-$0.08
-$0.22
-
Expected
-$0.13
$0.00
$0.01
-$0.20
-$0.14
Surprise
-131.63%
1,025.11%
-1,433.33%
9.93%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Inari Medical stock?

Inari Medical (NARI) has a market cap of $2.9B as of July 04, 2024.

What is the P/E ratio for Inari Medical stock?

The price to earnings (P/E) ratio for Inari Medical (NARI) stock is 0 as of July 04, 2024.

Does Inari Medical stock pay dividends?

No, Inari Medical (NARI) stock does not pay dividends to its shareholders as of July 04, 2024.

When is the next Inari Medical dividend payment date?

Inari Medical (NARI) stock does not pay dividends to its shareholders.

What is the beta indicator for Inari Medical?

Inari Medical (NARI) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Inari Medical stock

Buy or sell Inari Medical stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing